Publications:1735
- Home
- Profiles
Gregg Stone, MD,FACC, FSCAI
- About Me
- Publications
About Me
Language
Position
About Me
Language
Position
Publications
Selected Publications
- Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial. Zhen Ge, Jing Kan, Xiaofei Gao, Afsar Raza, Jun Jie Zhang, Bilal S. Mohydin, Fentang Gao, Yibing Shao, Yan Wang, Hesong Zeng, Feng Li, Hamid Sharif Khan, Naeem Mengal, Hongliang Cong, Mingliang Wang, Lianglong Chen, Yongyue Wei, Feng Chen, Gregg W. Stone, Shao Liang Chen, Xiaobo Li, Muhammed Anjum, Fei Ye, Anjum Jalal, Ping Xie, Ling Tao, Xiang Chen, Hamid S. Khan, Asim Javed, Yibin Shao, Xiaomei Guo, Tahir Saghir, Shaoping Nie, Hong Qu, Xuesong Qian, Song Yang, Jing Chen, Dasheng Gao, Lijun Liu, Fan Liu, Tan Xu, Yinwu Liu, Badar Ul Ahad Gill, Qing Yang, Nin Guo, Shangyu Wen, Lang Hong, Imad Sheiban, Gary S. Mintz. The Lancet
- Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial. Seung Jung Park, Jung Min Ahn, Do Yoon Kang, Sung Cheol Yun, Young Keun Ahn, Won Jang Kim, Chang Wook Nam, Jin Ok Jeong, In Ho Chae, Hiroki Shiomi, Hsien Li Kao, Joo Yong Hahn, Sung Ho Her, Bong Ki Lee, Tae Hoon Ahn, Ki Yuk Chang, Jei Keon Chae, David Smyth, Gary S. Mintz, Gregg W. Stone, Duk Woo Park, Chang Wook Nam Nam, Hiroki Shiomi Shiomi, Jei Keon Chae, Gary Mintz, Gregg Stone. The Lancet
- Regurgitant volume to LA volume ratio in patients with secondary MR: the COAPT trial. Augustin Coisne, Andrea Scotti, Juan F. Granada, Paul A. Grayburn, Michael J. Mack, David J. Cohen, Saibal Kar, D. Scott Lim, Jo Ann Lindenfeld, Jeroen Bax, Lak N. Kotinkaduwa, Björn Redfors, Neil J. Weissman, Federico M. Asch, Gregg W. Stone. European Heart Journal Cardiovascular Imaging